Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-20-004619
Date:2020-06-18
Issuer: BLUEBIRD BIO, INC. (BLUE)
Original Submission Date:

Reporting Person:

MELTON DOUGLAS
C/O BLUEBIRD BIO, INC.
60 BINNEY STREET CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-06-18 A 124 a $0.00 4,824 direct
COMMON STOCK 2020-06-18 A 1,500 a $0.00 6,324 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 64.09 2020-06-18 deemed execution date A 3,000 (a) 2030-06-18 common stock 3,000 $64.09 3,000 direct
Footnotes
IDfootnote
f1 these restricted stock units for common stock vest 100% on the earlier of june 18, 2021 or the date of the next annual meeting of stockholders.
f2 this option vests 100% on the earlier of june 18, 2021 or the date of the next annual meeting of stockholders.
WhaleWisdom Logo

Elevate your investments